Safety of endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer within a year after percutaneous coronary intervention.
Hyun-Il GilJunsu ChoeByeong-Ho JeongSang-Won UmKyeongman JeonJoo-Yong HahnHojoong KimO Jung KwonYoon Soo ChangKyungjong LeePublished in: Thoracic cancer (2018)
EBUS-TBNA was safe and did not cause serious adverse events in patients with lung cancer who required tissue confirmation or mediastinal staging within one year after PCI. Incidental lung cancer found during or after a coronary intervention should be actively evaluated by EBUS-TBNA.
Keyphrases
- ultrasound guided
- percutaneous coronary intervention
- fine needle aspiration
- coronary artery disease
- acute myocardial infarction
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- antiplatelet therapy
- randomized controlled trial
- coronary artery bypass grafting
- lymph node
- coronary artery
- atrial fibrillation
- heart failure
- left ventricular